HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Read responses to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in ADC Online Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haines, L Articles by Wilkinson, A R Search for Related Content PubMed PubMed Citation Articles by Haines, L Articles by Wilkinson, A R Topic Collections Related Article

UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome

¹ Royal College of Paediatrics and Child Health, London, UK
² Department of Ophthalmology, Imperial College London, UK
³ Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Oxford, UK

Correspondence to:
Correspondence to:
Professor Wilkinson
Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK; andrew.wilkinson{at}paediatrics.ox.ac.uk

Background: Retinopathy of prematurity (ROP) is one of the few causes of childhood blindness in which severe vision impairment is largely preventable. Ophthalmic screening for ROP is required to identify disease that requires treatment whereby the development of potentially blinding disease can be minimised.

Objectives: To make the first UK population based estimate of the incidence of babies with severe ROP (stage 3 or more); to document their clinical characteristics and management and to evaluate the appropriateness of current ROP screening guidelines in the UK.

Patients: Cases were recruited through a national surveillance programme with 1 year ophthalmic follow up and data from clinician completed questionnaires.

Results: Between 1 December 1997 and 31 March 1999, 233 preterm babies with stage 3 ROP were identified. Severity (location, extent, and presence of plus disease) was associated with degree of prematurity, most severe in the most premature babies. Fifty nine percent were treated. The UK screening protocol was followed in two thirds of cases, but in the remainder it was begun too late or was too infrequent. Three quarters of the cases were followed up at 1 year, and 13% had a severe vision deficit as a result of ROP.

Conclusions: Visual deficit as a result of ROP in premature babies continues to be a severe disability in some of the survivors of neonatal intensive care. Further efforts are needed to organise treatment regionally to improve outcome and standards of practice.

Keywords: retinopathy of prematurity; screening

Related Article

Fantoms

Ben Stenson
Arch. Dis. Child. Fetal Neonatal Ed. 2005 90: F189. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				S Varughese, C Gilbert, C Pieper, and C Cook Retinopathy of prematurity in South Africa: an assessment of needs, resources and requirements for screening programmes Br. J. Ophthalmol., July 1, 2008; 92(7): 879 - 882. [Abstract] [Full Text] [PDF]

				D A Todd, A Wright, J Smith, and the NICUS Group Severe retinopathy of prematurity in infants <30 weeks' gestation in New South Wales and the Australian Capital Territory from 1992 to 2002 Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2007; 92(4): F251 - F254. [Abstract] [Full Text] [PDF]

				M. E. Msall The retina as a window to the brain in vulnerable neonates. Pediatrics, June 1, 2006; 117(6): 2287 - 2289. [Full Text] [PDF]

				ROP claims sight needlessly Br. J. Ophthalmol., September 1, 2005; 89(9): 1096 - 1096. [Full Text] [PDF]

eLetters: